Clinical Response to Anti-Fungal Therapy in Dogs Affected  with Malasseziasis

Authors

  • Swethasri Paduvarahalli Thammanna Ph.D. Scholar, Department of Veterinary Medicine, College of Veterinary Sciences, GADVASU, Ludhiana, Punjab-141001, India.
  • Srikala Devarakonda Department of Veterinary Medicine, College of Veterinary Science, Sri Venkateswara Veterinary University, Tirupati-517501, Andhra Pradesh, India
  • Shobha Mani Bollam Department of Veterinary Medicine, College of Veterinary Science, Sri Venkateswara Veterinary University, Tirupati-517501, Andhra Pradesh, India
  • Raghunath Mulinti Department of Surgery & Radiology, Veterinary Clinical Complex, College of Veterinary Science, Sri Venkateswara Veterinary University, Tirupati-517501, Andhra Pradesh, India

DOI:

https://doi.org/10.48165/ijvsbt.22.3.10

Keywords:

Antifungal therapy, Canine malasseziasis, Cytology, Epidemiology, Malassezia pachydermatis.

Abstract

Canine malassezia is an important opportunistic yeast dermatitis commonly associated with underlying dermatological and systemic  disorders. The present investigation was undertaken to know the prevalence, epidemiological factors, clinical manifestations, diagnostic  techniques, haemato-biochemical alterations and therapeutic response in dogs affected with malasseziasis. During a six-month study  period, 2764 dogs presented with dermatological conditions were screened, of which 515 dogs (18.63%) were confirmed positive  for Malassezia pachydermatis. Higher prevalence was recorded in dogs aged 4-8 years (31.36%), males (62.91%) and Labrador Retrievers  (13.98%). Malasseziasis was frequently associated with ectoparasitic infestation (33.3%), pyoderma (23.8%) and demodicosis (20.0%).  Predominant clinical signs included pruritus, alopecia, erythema, hyperpigmentation and offensive odour. Tape impression cytology  proved to be the most sensitive diagnostic method (86.79%). Twenty affected dogs were divided into two equal groups and were subjected  to antifungal therapy tablet ketoconazole (Gr I) and itraconazole (Gr II) @ 5 mg/kg b.wt. for 30 days along with tablet cephalexin @ 15  mg/kg b.wt., liver protectant and haematinic syrup for three weeks, and evaluated for haemato-biochemical changes. The improvement  was seen in both the groups, but the liver enzymes were elevated in the group I with ketoconazole. Significant improvement in clinical  signs and normalization of haematological parameters were observed following treatment. The study emphasizes the importance of  early diagnosis and appropriate antifungal therapy for effective management of canine malasseziasis. 

 

Downloads

Download data is not yet available.

References

Anju, K. D., David, P. V., Ravishankar, C., Sindhu, O. K., & Ajithkumar, S. (2021). Diagnosis and therapeutic management of malasseziosis in dogs. Journal of Veterinary and Animal Sciences, 52(3), 262–266.

Ashwini, M. (2018). Malasseziosis infection in a dog. Journal of Dairy and Veterinary Sciences, 7(1), 1–2.

Bajwa, J. (2017). Canine Malassezia dermatitis. The Canadian Veterinary Journal, 58(10), 1119.

Bensignor, E. (2008). Oral itraconazole as a pulse therapy for the treatment of canine Malassezia dermatitis: A randomized, blinded, comparative trial. European Journal of Companion Animal Practice, 18, 69–72.

Brito, E. H. S., Fontenelle, R. O. S., Brilhante, R. S. N., Cordeiro, R. A., Monteiro, A. J., Sidrim, J. J., & Rocha, M. F. (2009). The anatomical distribution and antimicrobial susceptibility of yeast species isolated from healthy dogs. The Veterinary Journal, 182(2), 320–326.

Craig, M. (2008). Disease facts: Malassezia (yeast) dermatitis. UK Veterinary Journal, 13, 1–3.

Eluk, O. A. J., Baker, K. P., & Fuller, H. (2003). Comparison of two sampling techniques for the detection of Malassezia pachydermatis on the skin of dogs with chronic dermatitis. The Veterinary Journal, 165, 119–124.

George, S., Yathiraj, S., & Bhat, N. M. (2012). Occurrence of malasseziosis in dogs. Indian Veterinary Journal, 89(6), 119–120.

Girão, M. D., Prado, M. R., Brilhante, R. S. N., Cordeiro, R. A., Monteiro, A. J., Sidrim, J. J. C., & Rocha, M. F. G. (2006). Malassezia pachydermatis isolated from normal and diseased external ear canals in dogs: A comparative analysis. The Veterinary Journal, 172, 544–548.

Jain, S., Suresh, R. V., Balachandran, C., & Srinivasan, S. (2007). Cytological and cultural examination of Malassezia dermatitis in dogs. Indian Veterinary Journal, 84, 182–183.

Joyce, J. (2011). Notes on small animal dermatology (pp. 134–136). John Wiley & Sons.

Kirby, N. A., Hester, S. L., & Bauer, J. E. (2007). Dietary fats and the skin and coat of dogs. Journal of the American Veterinary Medical Association, 230(11), 1641–1644.

Kirk, N. M. (2020). The use of glutathione in canine itraconazole-associated hepatotoxicity (Doctoral dissertation, University of Illinois at Urbana-Champaign).

Kumar, A., Singh, K., & Sharma, A. (2002). Incidence of Malassezia pachydermatis and other organisms in healthy and infected dogs’ ears. Israel Journal of Veterinary Medicine, 57(4), 145–148.

Kumar, K. S., Latha, S. M., Prasanna, J. S., Dhanalakshmi, K., & Sarma, B. J. R. (2008). Cultural and electron microscopic studies of Malassezia pachydermatis. Indian Veterinary Journal, 85, 371–374.

Lewis, D. T. (2016). Malassezia dermatitis. In M. Schaer, F. Gaschen, & S. Walton (Eds.), Clinical medicine of the dog and cat (pp. 785–786). CRC Press.

Marchegiani, A., Fruganti, A., Spaterna, A., Dalle Vedove, E., Bachetti, B., Massimini, M., Di Pierro, F., Gavazza, A., & Cerquetella, M. (2020). Impact of nutritional supplementation on canine dermatological disorders. Veterinary Sciences, 7(2), 38.

Matousek, J. L., & Campbell, K. L. (2002). Malassezia dermatitis. Compendium, 24(3), 224–232.

Nobre, M. O., Castro, A. P., Nascente, P. S., Ferreiro, L., & Meireles, M. C. A. (2001). Occurrence of Malassezia pachydermatis and other infectious agents as cause of external otitis in dogs. Brazilian Journal of Microbiology, 32, 245–249.

Nuttall, T. (2012). Malassezia dermatitis. In BSAVA manual of canine and feline dermatology (pp. 198–205). BSAVA.

Paterson, S. (2008). Malasseziasis. In Manual of skin diseases of the dog and cat (pp. 67–69). John Wiley & Sons.

Prado, M. R., Brilhante, R. S. N., Cordeiro, R. A., Monteiro, A. J., Sidrim, J. J. C., & Rocha, M. F. G. (2008). Frequency of yeasts and dermatophytes from healthy and diseased dogs. Journal of Veterinary Diagnostic Investigation, 20, 197–202.

Rhodes, K. H., & Werner, A. H. (2018). Blackwell’s five-minute veterinary consult clinical companion: Small animal dermatology (pp. 480–493). Wiley-Blackwell.

Rosales, M. S., Marsella, R., Kunkle, G., Harris, B. L., Nicklin, C. F., & Lopez, J. (2005). Comparison of clinical efficacy of oral terbinafine and ketoconazole combined with cephalexin in the treatment of Malassezia dermatitis in dogs. Veterinary Dermatology, 16, 171–176.

Sickafoose, L., Hosgood, G., Snook, T., Westermeyer, R., & Merchant, S. (2010). A non-inferiority clinical trial comparing fluconazole and ketoconazole in combination with cephalexin for the treatment of dogs with Malassezia dermatitis. Research in Applied Veterinary Medicine, 11(2), E1–1.

Published

2026-04-16

How to Cite

Thammanna, S. P., Devarakonda, S., Bollam, S. M., & Mulinti, R. (2026). Clinical Response to Anti-Fungal Therapy in Dogs Affected  with Malasseziasis. Indian Journal of Veterinary Sciences and Biotechnology, 22(3), 51-56. https://doi.org/10.48165/ijvsbt.22.3.10